Oncolytic Virotherapy Market
According to Intent Market Research, the Oncolytic Virotherapy Market is expected to grow from USD 0.8 billion in 2024-e at a CAGR of 20.8% to touch USD 2.5 billion by 2030. The Oncolytic Virotherapy Market is dominated by key players such as, Oncolytics Biotech Inc., Amgen Inc., Jennerex Biotherapeutics (acquired by SillaJen), ViroMed Co. Ltd., and Viralytics Ltd. (acquired by Merck).